MAD2L1介导的NANOG核转位:肺癌化学抵抗的一个关键因素

Hongye Zhao1, Yongcun Liu2, Longyu Zhu3

  • 1The Department of Dermatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.

Cellular signalling
|April 15, 2025
PubMed
概括

线粒体停滞缺陷2像1 (MAD2L1) 通过启用NANOG核定位来促进肺癌化学抵抗. 降低MAD2L1可提高药物敏感性,提供一种潜在的治疗策略.